Investing

Also, MedEasy has raised seed funding to expand its user base in Bangladesh.

The funding will support the University of Melbourne-led project's pilot in Australia.

The company's computational solution uses AI, modeling and data analysis of naturally occurring proteins to generate superior antibodies, enzymes and vaccine immunogens.

Anca del Rio, a Basel health tech arena leader, relays her experience as a judge at the Startup PitchFest at HIMSS23 Europe, and the factors startups need to possess to go to market and scale successfully, including attraction capital.

Also, DeepTek and Alveofit obtained respective regulatory approvals in Thailand and the United States.

Filipe Santos Costa, CEO and chairman of Portugal's international trade and investment agency AICEP, discusses trade and investments in healthcare in the country and its work with HIMSS to promote Portuguese healthcare services abroad.

Also, Abbott has launched its vertigo support app in India. 

Medication management platform PatchRx and brain health company Neurpowyzer also garnered investment.

The company will use the funds to meet the growing demand for ElliQ, its conversational AI-powered robot that acts as a companion to seniors.

The raise brings the healthcare-focused firm's total committed capital to more than $1 billion.